Pregnancy Outcomes in Women Exposed to Golimumab - Update

(1) Janssen Biologics B.V.,Leiden,Netherlands

(2) Janssen Research & Development, LLC,Horsham,United States



This item was part of the IBD II (Posters) session at UEG Week 2019

This item can be cited as: United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019